4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-22-000096
Director acquired 5,986 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Tessier-Lavigne Marc · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-06-02 | Grant or award : show line 1 in the form | +5,986 | 2,030,356 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-06-02 | Grant or award : show line 2 in the form Stock Option (right to buy) | +17,959 | 17,959 | D |
Loading xslF345X03/wf-form4_165456054624289.xml…